bluebird bio (BLUE) PT Raised to $9 at BofA Securities
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry raised the price target on bluebird bio (NASDAQ: BLUE) to $9.00 (from $8.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
